spacer
home > ict > autumn 2016 > the patient chronicle
PUBLICATIONS
International Clinical Trials

The Patient Chronicle

Electronic health records (EHRs) are longitudinal, digital registers of patient health information that can include patient demographics, progress notes, medications, vital signs, past medical history, immunisations, laboratory data and radiology reports (1). Every patient interaction with a healthcare provider produces data; EHRs can store this information and capture the health of a patient across time. The widespread adoption of EHRs is generating comprehensive quantitative and qualitative datasets that could provide many advantages for patients and healthcare companies, but that are also associated with certain obstacles.

Potential Gains


EHRs offer numerous benefits that could possibly transform healthcare, and significantly enhance clinical decisions and patient outcomes. They strengthen healthcare delivery, reduce costs and enable clinicians to make well-informed treatment decisions quickly and safely.

For example, patient safety might be improved when EHRs maintain a record of medications and allergies. When data are accurately inputted into an EHR, the clinician is then able to check for problems such as potential prescribing of conflicting drugs. This lowers the incidence of medical errors, as well as avoids unnecessary patient concerns and additional treatment costs that might be incurred in the event of drug interactions (2). The utilisation of EHRs could also identify patients who are due for preventative visits and screenings, meaning earlier diagnosis and possible hindrance of disease development. In the US, for instance, EHRs can provide these benefits through the following functionalities: clinical decision support tools, computerised physician order entry systems and health information exchange (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Martin Gibson is Chief Executive of NorthWest EHealth, Director of the National Institute for Health Research in Clinical Research for Greater Manchester and Research and Informatics Director for the Greater Manchester Academic Health Science Network. He is also a Consultant Doctor specialising in diabetes and lipid disorders at the Salford Royal NHS Foundation Trust, where he was formerly R&D Director of both the acute and primary care trusts.
spacer
Martin Gibson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement